{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:12Z","timestamp":1761986472877},"reference-count":0,"publisher":"Oceanside Publications Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2013,5,1]]},"DOI":"10.2500\/aap.2013.34.3661","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T18:10:43Z","timestamp":1367691043000},"page":"197-204","source":"Crossref","is-referenced-by-count":13,"title":["Oral and sublingual peanut immunotherapy is not ready for general use"],"prefix":"10.2500","volume":"34","author":[{"given":"Matthew J.","family":"Greenhawt","sequence":"first","affiliation":[{"name":"Department of Allergy and Clinical Immunology, University of Michigan Medical School, University of Michigan Health Systems, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2013\/00000034\/00000003\/art00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T09:13:17Z","timestamp":1513069997000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2013.34.3661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5,1]]}},"alternative-id":["1088-5412(20130501)34:3L.197;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2013.34.3661","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5,1]]}}}